Benefits
PrenatalSAFE® Karyo Plus detects 99,1% of chromosomal abnormalities observed at birth PrenatalSAFE® Karyo
test identifies 92.6% of chromosomal
anomalies prenatally detected and 96.2% of
those anomalies observed at birth.
PrenatalSAFE® Karyo Plus
test identifies 95.5% of chromosomal
anomalies prenatally detected and 99.1% of
those anomalies observed at birth, achieving
a level of detection rate very closed to the
traditional fetal karyotyping (96.9%),
obtained with invasive, prenatal diagnostic
techniques
Unlike any other non-invasive prenatal test available to date PrenalSAFE Karyo offers a level of information previously only available from a fetal karyotype analysis, performed with invasive prenatal diagnosis procedures (amniocentesis and CVS)
